• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

合成及评价不同连接子标记的 FAP 抑制剂用于肿瘤中纤维母细胞激活蛋白的成像。

Synthesis and Evaluation of Tc-Labeled FAP Inhibitors with Different Linkers for Imaging of Fibroblast Activation Proteins in Tumors.

机构信息

Key Laboratory of Radiopharmaceuticals of the Ministry of Education, NMPA Key Laboratory for Research and Evaluation of Radiopharmaceuticals (National Medical Products Administration), College of Chemistry, Beijing Normal University, Beijing 100875, P. R. China.

Key Laboratory of Beam Technology of the Ministry of Education, College of Nuclear Science and Technology, Beijing Normal University, Beijing 100875, P. R. China.

出版信息

J Med Chem. 2023 Apr 13;66(7):4952-4960. doi: 10.1021/acs.jmedchem.2c02062. Epub 2023 Mar 27.

DOI:10.1021/acs.jmedchem.2c02062
PMID:36972467
Abstract

Fibroblast activation protein (FAP) is a potential target for tumor diagnosis and treatment due to its selective expression on cancer-associated fibroblasts (CAFs) in most solid tumor stroma. Two FAP inhibitor (FAPI) derived ligands (L1 and L2) containing different lengths of Pro-Gly (PG) repeat units as linkers were designed and synthesized with high affinity for FAP. Two stable hydrophilic Tc-labeled complexes ([Tc]Tc-L1 and [Tc]Tc-L2) were obtained. cellular studies show that the uptake mechanism is correlated with FAP uptake, and [Tc]Tc-L1 shows a higher cell uptake and specific binding to FAP. A nanomolar value for [Tc]Tc-L1 indicates its significantly high target affinity for FAP. The biodistribution and microSPECT/CT images obtained for U87MG tumor mice show that [Tc]Tc-L1 has high tumor uptake with specificity to FAP and high tumor-to-nontarget ratios. As an inexpensive, easily made, and widely available tracer, [Tc]Tc-L1 holds great promise for clinical applications.

摘要

成纤维细胞激活蛋白(FAP)在大多数实体肿瘤基质中的癌相关成纤维细胞(CAFs)上选择性表达,因此成为肿瘤诊断和治疗的潜在靶点。设计并合成了两种含有不同长度脯氨酸-甘氨酸(PG)重复单元作为连接物的 FAP 抑制剂(FAPI)衍生配体(L1 和 L2),它们对 FAP 具有高亲和力。获得了两种稳定的亲水性 Tc 标记的配合物([Tc]Tc-L1 和 [Tc]Tc-L2)。细胞研究表明,摄取机制与 FAP 摄取相关,[Tc]Tc-L1 表现出更高的细胞摄取和对 FAP 的特异性结合。[Tc]Tc-L1 的纳摩尔值表明其对 FAP 的靶标亲和力显著较高。U87MG 肿瘤小鼠的生物分布和 microSPECT/CT 图像显示,[Tc]Tc-L1 具有高肿瘤摄取特异性和高肿瘤与非靶标比值。作为一种廉价、易于制备且广泛可用的示踪剂,[Tc]Tc-L1 在临床应用中具有很大的应用前景。

相似文献

1
Synthesis and Evaluation of Tc-Labeled FAP Inhibitors with Different Linkers for Imaging of Fibroblast Activation Proteins in Tumors.合成及评价不同连接子标记的 FAP 抑制剂用于肿瘤中纤维母细胞激活蛋白的成像。
J Med Chem. 2023 Apr 13;66(7):4952-4960. doi: 10.1021/acs.jmedchem.2c02062. Epub 2023 Mar 27.
2
A Simple Kit Formulation for Preparation and Exploratory Human Studies of a Novel Tc-Labeled Fibroblast Activation Protein Inhibitor Tracer for Imaging of the Fibroblast Activation Protein in Cancers.一种简单的试剂盒配方,用于制备和探索新型 Tc 标记的成纤维细胞激活蛋白抑制剂示踪剂,用于癌症中成纤维细胞激活蛋白的成像。
Mol Pharm. 2023 Jun 5;20(6):2942-2950. doi: 10.1021/acs.molpharmaceut.2c01094. Epub 2023 Apr 21.
3
Preparation and Bioevaluation of Tc-Labeled FAP Inhibitors as Tumor Radiotracers to Target the Fibroblast Activation Protein.Tc 标记的 FAP 抑制剂作为肿瘤放射性示踪剂的制备与生物评价:靶向成纤维细胞激活蛋白。
Mol Pharm. 2022 Jan 3;19(1):160-171. doi: 10.1021/acs.molpharmaceut.1c00712. Epub 2021 Dec 14.
4
Synthesis and Preclinical Evaluation of Novel Tc-Labeled FAPI-46 Derivatives with Significant Tumor Uptake and Improved Tumor-to-Nontarget Ratios.新型 Tc 标记的 FAPI-46 衍生物的合成及临床前评价:显著提高肿瘤摄取率和改善肿瘤与非靶比值。
J Med Chem. 2024 Feb 22;67(4):3190-3202. doi: 10.1021/acs.jmedchem.4c00031. Epub 2024 Feb 6.
5
Synthesis and Preliminary Study of Tc-Labeled HYNIC-FAPi for Imaging of Fibroblast Activation Proteins in Tumors.Tc-标记的 HYNIC-FAPi 的合成及初步研究用于肿瘤中纤维母细胞激活蛋白的成像。
Mol Pharm. 2024 Feb 5;21(2):735-744. doi: 10.1021/acs.molpharmaceut.3c00886. Epub 2024 Jan 9.
6
Design and Development of Tc-Labeled FAPI Tracers for SPECT Imaging and Re Therapy.Tc 标记 FAPI 示踪剂的设计与开发用于 SPECT 成像和再治疗。
J Nucl Med. 2020 Oct;61(10):1507-1513. doi: 10.2967/jnumed.119.239731. Epub 2020 Mar 13.
7
Design, Synthesis and Preclinical Assessment of Tc-iFAP for In Vivo Fibroblast Activation Protein (FAP) Imaging.设计、合成及 Tc-iFAP 的临床前评估用于体内成纤维细胞激活蛋白(FAP)成像。
Molecules. 2022 Jan 1;27(1):264. doi: 10.3390/molecules27010264.
8
SPECT Imaging with Tc-99m-Labeled HYNIC-FAPI-04 to Extend the Differential Time Window in Evaluating Tumor Fibrosis.用Tc-99m标记的HYNIC-FAPI-04进行单光子发射计算机断层显像以延长评估肿瘤纤维化的鉴别时间窗。
Pharmaceuticals (Basel). 2023 Mar 10;16(3):423. doi: 10.3390/ph16030423.
9
Tc-labeled FAPI compounds for cancer and inflammation: from radiochemistry to the first clinical applications.用于癌症和炎症的锝标记FAPI化合物:从放射化学到首次临床应用
EJNMMI Radiopharm Chem. 2024 May 2;9(1):36. doi: 10.1186/s41181-024-00264-0.
10
IDH-wildtype glioblastomas and grade III/IV IDH-mutant gliomas show elevated tracer uptake in fibroblast activation protein-specific PET/CT.IDH 野生型胶质母细胞瘤和 3/4 级 IDH 突变型胶质瘤在成纤维细胞激活蛋白特异性 PET/CT 中呈现出摄取增高。
Eur J Nucl Med Mol Imaging. 2019 Nov;46(12):2569-2580. doi: 10.1007/s00259-019-04444-y. Epub 2019 Aug 6.

引用本文的文献

1
Advances in nanotechnology for targeting cancer-associated fibroblasts: A review of multi-strategy drug delivery and preclinical insights.靶向癌症相关成纤维细胞的纳米技术进展:多策略药物递送及临床前见解综述
APL Bioeng. 2025 Mar 13;9(1):011502. doi: 10.1063/5.0244706. eCollection 2025 Mar.
2
Development of Novel Tc-Labeled Hydrazinoicotinamide-Modified Ubiquicidin 29-41 Complexes with Improved Target-to-Nontarget Ratios for Bacterial Infection Imaging.新型锝标记的肼基烟酰胺修饰的泛杀菌素29-41复合物的研发,用于细菌感染成像,其靶标与非靶标比率得到改善。
ACS Pharmacol Transl Sci. 2025 Feb 4;8(2):470-483. doi: 10.1021/acsptsci.4c00599. eCollection 2025 Feb 14.
3
Unveiling the Tumor Microenvironment Through Fibroblast Activation Protein Targeting in Diagnostic Nuclear Medicine: A Didactic Review on Biological Rationales and Key Imaging Agents.
通过诊断核医学中靶向成纤维细胞活化蛋白揭示肿瘤微环境:关于生物学原理和关键显像剂的教学综述
Biology (Basel). 2024 Nov 24;13(12):967. doi: 10.3390/biology13120967.
4
Tc-labeled FAPI compounds for cancer and inflammation: from radiochemistry to the first clinical applications.用于癌症和炎症的锝标记FAPI化合物:从放射化学到首次临床应用
EJNMMI Radiopharm Chem. 2024 May 2;9(1):36. doi: 10.1186/s41181-024-00264-0.
5
Diagnostic and Therapeutic Radiopharmaceuticals: A "Hot" Topic.诊断与治疗用放射性药物:一个“热门”话题。
ACS Pharmacol Transl Sci. 2023 Dec 18;7(1):1-7. doi: 10.1021/acsptsci.3c00347. eCollection 2024 Jan 12.
6
Synthesis and Evaluation of Tc-Labelled 2-Nitroimidazole Derivatives with Different Linkers for Tumour Hypoxia Imaging.用于肿瘤乏氧成像的含不同连接基的锝标记2-硝基咪唑衍生物的合成与评价
Pharmaceuticals (Basel). 2023 Sep 9;16(9):1276. doi: 10.3390/ph16091276.
7
Theranostics in targeting fibroblast activation protein bearing cells: Progress and challenges.靶向成纤维细胞激活蛋白阳性细胞的治疗学研究:进展与挑战。
Life Sci. 2023 Sep 15;329:121970. doi: 10.1016/j.lfs.2023.121970. Epub 2023 Jul 21.